Your browser doesn't support javascript.
loading
Simultaneous Targeting of FcγRs and FcαRI Enhances Tumor Cell Killing.
Brandsma, Arianne M; Ten Broeke, Toine; Nederend, Maaike; Meulenbroek, Laura A P M; van Tetering, Geert; Meyer, Saskia; Jansen, J H Marco; Beltrán Buitrago, M Alejandra; Nagelkerke, Sietse Q; Németh, István; Ubink, Ruud; Rouwendal, Gerard; Lohse, Stefan; Valerius, Thomas; Leusen, Jeanette H W; Boross, Peter.
Affiliation
  • Brandsma AM; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands.
  • Ten Broeke T; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands.
  • Nederend M; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands.
  • Meulenbroek LA; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands.
  • van Tetering G; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands.
  • Meyer S; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands.
  • Jansen JH; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands.
  • Beltrán Buitrago MA; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands.
  • Nagelkerke SQ; Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, the Netherlands.
  • Németh I; Developmental Drug Metabolism and Pharmacokinetics, Gedeon Richter Plc, Budapest, Hungary.
  • Ubink R; Synthon Biopharmaceuticals B.V., Nijmegen, the Netherlands.
  • Rouwendal G; Synthon Biopharmaceuticals B.V., Nijmegen, the Netherlands.
  • Lohse S; Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, Christian-Albrechts-University, Kiel, Germany.
  • Valerius T; Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, Christian-Albrechts-University, Kiel, Germany.
  • Leusen JH; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands. jleusen@umcutrecht.nl.
  • Boross P; Immunotherapy Laboratory, Laboratory for Translational Immunology, UMC Utrecht, the Netherlands.
Cancer Immunol Res ; 3(12): 1316-24, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26407589
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Fc / Antigens, CD / Receptors, IgG / Receptor, ErbB-2 / ErbB Receptors / Cetuximab / Trastuzumab / Immunotherapy / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Res Year: 2015 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Fc / Antigens, CD / Receptors, IgG / Receptor, ErbB-2 / ErbB Receptors / Cetuximab / Trastuzumab / Immunotherapy / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Immunol Res Year: 2015 Document type: Article Affiliation country: Country of publication: